Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


Pluristem Develops Point-of-Care Thawing Device for PLX Cells 

 

Pluristem Develops Point-of-Care Thawing Device for PLX Cells
NASDAQ
As part of the company's comprehensive approach in developing high quality, easy to use PLX cell therapy candidate products, the device ensures the uniform thawing of PLX cells across all doses. Pluristem's "off-the-shelf" PLX cell therapy product ...
See all stories on this topic »

 

Posted on 18-Oct-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: